Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here. The fourth quarter of 2025 saw mixed results for midcap stocks. Among the style indexes, the Russell Midcap® Growth Index decreased by 3.70%, while the Russell Midcap® Value Index rose by 1.41%. In the growth index, materials achieved the highest absolute return at 17.51%. However, due to their smaller weight in the index, their contribution to overall returns was limited. The healthcare (up 1.13%) and real estate (up 0.24%) sectors were the only other positive contributing sectors. Midcap stocks generated positive returns in 2025 but trailed their 2024 annual returns. The Russell Midcap Growth Index rose by 8.66%, trailing the Russell Midcap Value Index’s 11.04% return. In the growth index, utilities recorded the highest absolute return among all sectors, up 29.40%. The firm anticipates a favorable year ahead for equity markets. The letter outlined potential opportunities in Cyclicals, Healthcare, Information Technology, Financials, and Consumer Spending sectors through 2026. Please review the Fund’s top five holdings to gain insights into their key selections for 2025.
In its fourth-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks like Veeva Systems Inc. (NYSE:VEEV). Veeva Systems Inc. (NYSE:VEEV) is a technology company that provides a cloud-based software platform for the life sciences industry. On March 3, 2026, Veeva Systems Inc. (NYSE:VEEV) stock closed at $185.91 per share. One-month return of Veeva Systems Inc. (NYSE:VEEV) was -2.51%, and its shares lost 15.47% over the past 52 weeks. Veeva Systems Inc. (NYSE:VEEV) has a market capitalization of $30.56 billion.
Carillon Eagle Mid Cap Growth Fund stated the following regarding Veeva Systems Inc. (NYSE:VEEV) in its fourth quarter 2025 investor letter:
“Veeva Systems Inc. (NYSE:VEEV) provides cloud-based software solutions for the life sciences industry. The stock struggled after third quarter results, as management acknowledged competitive losses despite otherwise solid performance. The company has introduced a suite of AI products aimed at mitigating these losses and sees opportunities to win back customers given its broad product portfolio. With its deep expertise in life sciences and a comprehensive platform, we believe Veeva remains well positioned to continue capturing market share.”
Veeva Systems Inc. (NYSE:VEEV) is not on our list of 40 Most Popular Stocks Among Hedge Funds. According to our database, 75 hedge fund portfolios held Veeva Systems Inc. (NYSE:VEEV) at the end of the fourth quarter, compared to 57 in the previous quarter. While we acknowledge the risk and potential of Veeva Systems Inc. (NYSE:VEEV) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Veeva Systems Inc. (NYSE:VEEV) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Veeva Systems Inc. (NYSE:VEEV) and shared Artisan Mid Cap Fund’s views on the company. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
